Immuron Ltd Files May 2024 6-K Report

Ticker: IMRN · Form: 6-K · Filed: May 31, 2024 · CIK: 1660046

Immuron LTD 6-K Filing Summary
FieldDetail
CompanyImmuron LTD (IMRN)
Form Type6-K
Filed DateMay 31, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, foreign-private-issuer, regulatory-update

Related Tickers: IMRN

TL;DR

Immuron Ltd (IMRN) filed a 6-K for May 2024, standard foreign issuer update.

AI Summary

Immuron Limited filed a Form 6-K on May 31, 2024, reporting information for the month of May 2024. The filing indicates that the company is a foreign private issuer and files annual reports under Form 20-F. No specific financial figures or operational updates were detailed in the provided excerpt.

Why It Matters

This filing provides routine updates for foreign private issuers, informing investors about the company's reporting status and adherence to SEC regulations.

Risk Assessment

Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information that would immediately impact risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers which provides information that the issuer makes or is required to make public pursuant to the laws of its home country, or is required to file with or submit to any stock exchange on which it has securities listed, or is distributed or is required to be distributed to its security holders.

Which form does Immuron Limited file for its annual reports?

Immuron Limited files its annual reports under cover of Form 20-F.

What is Immuron Limited's principal executive office address?

Immuron Limited's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.

Does Immuron Limited furnish information to the SEC pursuant to Rule 12g3-2(b)?

No, Immuron Limited indicated 'No' for furnishing information pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

What is the filing date of this Form 6-K?

This Form 6-K was filed on May 31, 2024.

Filing Stats: 326 words · 1 min read · ~1 pages · Grade level 17.2 · Accepted 2024-05-31 08:00:38

Filing Documents

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May 2024 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on May 31, 2024 titled: - “Immuron CEO Steven Lydeamore to present at Peak Sky High” - “Board Changes” A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Immuron CEO Steven Lydeamore to present at Peak Sky High 99.2 Board Changes 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: May 31, 2024 By: /s/ Phillip Hains Phillip Hains Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing